Back to Search
MONICA BROCCO, MD
MD
Emergency Medicine Physician
NPI: 1851610810Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
PMID 18657401·Eur Neuropsychopharmacol·2008
4-observational
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
PMID 17021388·Behav Pharmacol·2006
7-preclinical
Neurotrophic factors and depolarization do not enhance viability and process regrowth on a purified set of chick embryo retinal ganglion cells.
PMID 12147311·Neurosci Lett·2002
7-preclinical
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
PMID 11888558·Pharmacol Biochem Behav·2002
7-preclinical
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
PMID 18830239·Neuropsychopharmacology·2009
7-preclinical
Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice.
PMID 18609297·Stress·2009
7-preclinical
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
PMID 18523738·Psychopharmacology (Berl)·2008
7-preclinical
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats.
PMID 18466669·Int J Neuropsychopharmacol·2008
7-preclinical
Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms.
PMID 18342838·Biochem Pharmacol·2008
7-preclinical
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
PMID 18096759·J Pharmacol Exp Ther·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, GROUND SILVERSTEIN BLDG
PHILADELPHIA, PA 19104 - Phone
- (215) 662-6698
Quick Facts
- NPI
- 1851610810
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile